Deal Structure Guide · Senior Care / Home Health

How to Structure a Home Health Agency Acquisition

From SBA financing and earnouts to equity rollovers, here is how buyers and sellers in the senior care and home health market structure deals that close — and hold up post-transition.

Acquiring or selling a home health or senior care agency in the $1M–$5M revenue range requires deal structures that account for the industry's unique risk profile: government payer dependency, caregiver retention uncertainty, licensing transfer complexity, and revenue that can shift quickly when ownership changes hands. Most transactions in this space are structured as asset purchases, preserving the buyer's ability to control Medicare and Medicaid certification applications and limit exposure to undisclosed regulatory liabilities. SBA 7(a) financing is the dominant capital source for individual buyers, while PE-backed platforms favor equity rollovers and earnouts to align seller incentives during integration. Regardless of deal type, deal structures in home health almost always include some form of risk-sharing mechanism — whether a seller note, earnout, or escrow holdback — tied to client retention, caregiver staffing continuity, or regulatory compliance milestones in the 12–24 months post-close.

Find Senior Care / Home Health Businesses For Sale

SBA 7(a) Loan with Seller Note

The most common structure for individual buyers acquiring home health agencies under $5M in revenue. The buyer obtains an SBA 7(a) loan — typically covering 80–90% of the purchase price — and the seller carries a subordinated note for the remaining gap. The SBA loan term is generally 10 years for a business acquisition with no commercial real estate. Seller notes in this structure are typically subordinated to the SBA lender and may include a standby period of 12–24 months where no payments are made.

SBA loan: 75–85% of purchase price | Seller note: 10–15% | Buyer equity injection: 10–20%

Pros

  • Enables buyers with $150K–$400K in liquid capital to acquire agencies with $500K–$1M+ in SDE without outside equity partners
  • Seller note signals seller confidence in the business and gives buyers a cushion against early post-closing surprises
  • SBA financing is government-backed, making lenders more willing to finance service businesses with intangible assets like Medicare certifications and client relationships

Cons

  • SBA lenders require the seller to be fully exited in most cases, limiting transition flexibility and prolonged seller involvement
  • Seller note is subordinated, meaning the seller may not collect if the business underperforms post-close
  • Full personal guarantee required from the buyer, creating significant personal financial exposure if caregiver retention or reimbursement issues materialize post-acquisition

Best for: Individual buyers or healthcare entrepreneurs acquiring an established Medicare or Medicaid certified agency with clean financials, at least 3 years of operating history, and $300K+ in SDE. Ideal when the seller wants a clean exit and is willing to carry 10–15% as a note.

Asset Purchase with Earnout

The seller receives a base payment at closing — funded by buyer equity, SBA, or PE capital — plus additional contingent payments tied to post-closing performance milestones. In home health, earnouts are most commonly structured around client census retention, billable hours maintained, or gross revenue thresholds over 12–24 months following close. This structure is frequently used when there is disagreement on valuation or when meaningful key-person risk exists around the owner's client and caregiver relationships.

Base payment at close: 70–85% of purchase price | Earnout: 15–30% contingent on 12–24 month performance milestones

Pros

  • Protects buyer from paying full value for revenue that may not transfer without the seller's involvement
  • Motivates the seller to actively support client and caregiver retention during the transition period
  • Bridges valuation gaps between what the seller believes the business is worth and what the buyer can justify based on verifiable, recurring revenue

Cons

  • Earnout disputes are common — clear, objective metrics like billable hours or client census must be defined with precision in the purchase agreement
  • Sellers may resist earnouts if they feel penalized for risks outside their control, such as caregiver turnover or Medicaid rate changes after close
  • Ongoing financial reporting and tracking obligations post-close can strain the relationship between buyer and seller if results are below expectations

Best for: Transactions where the selling owner plays a central role in client relationships, caregiver recruitment, or referral source management, and where the buyer needs confidence that revenue will hold before paying full asking price. Common in companion care and non-medical home care agency deals.

Equity Rollover with PE-Backed Buyer

A private equity platform or regional roll-up acquires a majority stake in the home health agency while the selling owner retains a 10–20% equity position in the combined or acquiring entity. The seller receives a significant liquidity event at close but participates in future upside through the retained equity stake. This structure is most common in PE-backed consolidation strategies where the seller's continued operational involvement — particularly around staff culture, clinical quality, and referral relationships — meaningfully de-risks the integration.

PE buyer acquires 80–90% at close | Seller retains 10–20% equity rollover in the combined platform

Pros

  • Seller benefits from two liquidity events: the initial close and a future exit when the PE platform sells or recapitalizes
  • Seller's retained stake aligns incentives, increasing the likelihood that key caregivers, clinical staff, and client families remain loyal post-acquisition
  • Buyers gain an experienced operator retained in an advisory or operational role, reducing integration execution risk in a highly relationship-driven industry

Cons

  • Seller relinquishes operational control and must adapt to PE reporting requirements, financial discipline, and integration timelines
  • Retained equity value depends entirely on the PE platform's future performance, which carries its own market and execution risk
  • Negotiating the terms of the rollover equity — valuation, liquidation preferences, and minority protections — requires experienced legal counsel and can slow deal timelines

Best for: Established home health agencies with $2M–$5M+ in revenue, strong clinical systems, and a seller willing to stay engaged for 12–36 months post-close. Most appropriate when a PE-backed roll-up is the buyer and the seller values participation in future upside alongside a clean initial liquidity event.

Sample Deal Structures

Individual buyer acquires a Medicare-certified home health agency with $1.8M revenue and $420K SDE using SBA financing

$1,680,000 (4.0x SDE)

SBA 7(a) loan: $1,344,000 (80%) | Seller note: $168,000 (10%) | Buyer cash equity injection: $168,000 (10%)

SBA loan at 10-year term, fully amortizing, at WSJ Prime + 2.75%. Seller note subordinated to SBA, 6% interest, 24-month standby period followed by 36-month repayment. Seller note contingent on no regulatory deficiencies discovered post-close. Asset purchase structure. All Medicare certifications and state licenses to be transferred or re-applied for within 90 days of close. 90-day seller transition and training period included at no additional cost.

PE-backed regional operator acquires a private-pay companion care agency with $3.2M revenue and $640K EBITDA, retaining seller for integration

$3,200,000 (5.0x EBITDA)

Cash at close to seller: $2,560,000 (80%) | Seller equity rollover into PE platform: $640,000 (20% retained stake valued at current platform multiple)

Asset purchase with seller retaining 20% equity in the acquiring platform entity. Seller remains as Regional Director of Operations for 24 months at a market-rate salary of $95,000 per year. Earnout of up to $320,000 payable over 24 months if client census remains above 85% of close-date levels and gross revenue does not decline more than 10%. Rollover equity subject to standard drag-along and tag-along provisions with PE sponsor. Seller's equity carries no liquidation preference over sponsor.

Healthcare entrepreneur acquires a Medicaid-heavy non-medical home care agency with $1.1M revenue and $310K SDE, with earnout tied to payer mix improvement

$1,085,000 (3.5x SDE base) with up to $155,000 in earnout

SBA 7(a) loan: $868,000 (80% of base) | Buyer equity injection: $217,000 (20%) | Earnout: up to $155,000 payable over 24 months

Asset purchase. Base purchase price of $1,085,000 reflects discounted multiple due to 78% Medicaid payer concentration. Earnout of $155,000 achievable in two tranches: $77,500 at month 12 if private-pay revenue reaches 20% of total billing, and $77,500 at month 24 if private-pay reaches 30% and total EBITDA is at or above $340,000. Seller to provide active referral introductions to three private-pay referral sources within 60 days of close. All caregiver W-2 classification reviewed and confirmed clean prior to close with indemnification from seller for pre-close misclassification claims.

Negotiation Tips for Senior Care / Home Health Deals

  • 1Request a minimum of 90 days of rolling accounts receivable aging reports prior to close to identify any Medicare or Medicaid claim denials, underpayments, or billing patterns that could signal audit risk or revenue quality problems that do not appear on the income statement.
  • 2Structure earnouts around objective, verifiable operational metrics — active client census, total billable hours per week, or gross collections from specified payer categories — rather than net income, which can be influenced by post-close buyer decisions on staffing, overhead, or growth investments.
  • 3Negotiate a regulatory indemnification clause requiring the seller to cover all costs associated with any pre-closing CMS survey findings, state licensing violations, HIPAA breaches, or billing audits that surface within 18–24 months of close, even if not yet discovered at the time of transaction.
  • 4In SBA-financed deals, confirm with your lender early whether the target's Medicare or Medicaid certifications will be treated as assignable intangible assets or will require a new owner enrollment — this directly impacts how licensing transfer is handled and can affect closing timelines by 60–120 days.
  • 5If the seller's personal relationships with key caregivers or referral sources represent a meaningful portion of the business's value, include a structured transition agreement with specific deliverables: a minimum number of caregiver introductions, referral source meetings attended with the buyer, and documented handoffs of active client care plans within the first 90 days post-close.
  • 6Use an escrow holdback of 5–10% of the purchase price held for 12 months post-close as protection against unknown liabilities, including pre-close caregiver classification disputes, undisclosed billing overpayments owed to Medicare or Medicaid, or state survey deficiencies that carry civil monetary penalty risk.

Find Senior Care / Home Health Businesses For Sale

Pre-screened targets ready for your deal structure — free to join.

Get Deal Flow

Frequently Asked Questions

What is the most common deal structure for buying a home health agency under $5M in revenue?

The most common structure is an asset purchase financed with an SBA 7(a) loan, with the buyer injecting 10–20% in equity and the seller carrying a subordinated note for 10–15% of the purchase price. This structure is popular because SBA financing is accessible to healthcare entrepreneurs without institutional capital, and the seller note aligns the seller's interests with a successful transition. The asset purchase format also gives buyers the ability to control the Medicare and Medicaid certification re-enrollment process and limits exposure to pre-existing regulatory liabilities.

How do earnouts work in home health agency acquisitions and what metrics are typically used?

Earnouts in home health are contingent payments made to the seller after close if specific performance targets are met — most commonly client census retention, billable hours, or gross revenue from specified payer categories. A typical structure pays 15–30% of the total purchase price in earnout over 12–24 months. Because client and caregiver relationships are highly personal in senior care, earnouts effectively shift the risk of relationship-dependent revenue to the seller, incentivizing them to actively support a successful ownership transition rather than walking away at closing.

Can you get an SBA loan to buy a Medicare or Medicaid certified home health agency?

Yes. Home health agencies are SBA-eligible businesses and SBA 7(a) loans are widely used to finance acquisitions in this sector. However, buyers should be aware that SBA lenders will scrutinize payer mix closely — agencies with heavy Medicaid concentration or thin margins may face lender skepticism. Lenders also evaluate whether Medicare and Medicaid certifications are assignable or require new owner enrollment, since unenrolled certifications can create revenue gaps post-close. Working with an SBA lender who has prior experience financing healthcare service businesses significantly improves the probability of approval.

What happens to Medicare and Medicaid certifications when a home health agency is sold?

Medicare and Medicaid certification transfer rules vary by deal structure. In an asset purchase, the buyer typically must apply for new Medicare enrollment under their own entity, which can take 60–120 days and may include a period without Medicare billing authority. Some states allow Medicare certification to be treated as a change of ownership (CHOW), which is faster but carries over the seller's compliance history. Medicaid contracts vary significantly by state and often require separate re-credentialing. Buyers should confirm the transfer approach with CMS and their state Medicaid agency before closing, and sellers should ensure all certifications and state licenses are in good standing before going to market.

How is a home health agency typically valued for sale, and what valuation multiple should I expect?

Home health and senior care agencies in the lower middle market are typically valued at 3.5x–6.0x SDE or EBITDA, depending on payer mix, revenue quality, regulatory compliance history, caregiver workforce stability, and client concentration. Private-pay agencies with low Medicaid dependency, clean CMS survey histories, and tenured management teams command the upper end of this range. Medicaid-heavy agencies with high caregiver turnover or concentrated client books are typically discounted to the 3.5x–4.5x range. Revenue of $1M–$5M generally corresponds to purchase prices of $1M–$5M+ depending on profitability and deal structure.

Should a home health agency seller accept an equity rollover with a private equity buyer?

An equity rollover can be an attractive structure if you are willing to stay involved operationally for 24–36 months and believe the PE platform's consolidation strategy will create a meaningful second liquidity event. Sellers who roll equity typically benefit from the platform's resources — centralized billing, HR support, and marketing — which can accelerate growth and increase the future value of their retained stake. However, sellers should negotiate carefully for minority protections, understand the PE sponsor's exit timeline, and ensure the rollover equity is valued fairly at the time of close. Sellers who want a clean exit with no ongoing involvement are better served by an all-cash or SBA-financed structure.

More Senior Care / Home Health Guides

More Deal Structure Guides

Start Finding Senior Care / Home Health Deals Today — Free to Join

Find the right target, structure the deal, and close with confidence.

Create your free account

No credit card required